INO

Conviction 11HealthcareScan · Thu, Jun 25, 2026

INO$1.09-1.36%

ResistanceSupportVol 14

Vol MA14 1.54M

Mar 26Apr 14May 1May 19Jun 8Jun 25

INOVIO PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.inovio.com ↗

Price1.09

Change-1.36%

Gap+1.36%

Rel volume1.53×

Avg volume1.52M

Avg $ vol1.73M

SMA 201.14

SMA 501.20

SMA 2001.75

Price vs 50-9.28%

Price vs 200-38.09%

MA stackbearish

50/200 cross—

Supertrenddown · 1.30

RSI (14)39

MACD hist0.00

MACD crossbull · 2d

Stoch %K / %D23 / 32

ADX (14)14

+DI / −DI17 / 21

RSI divergence—

MACD divergence—

ATR %+6.78%

ADR %5.35%

52w high2.87

52w low1.05

From 52w high-62.20%

Above 52w low+3.33%

New 52w highNo

SqueezeOff

Bollinger width25.26%

%B0.31

Donchian pos8.33%

Donchian high1.36

Donchian low1.06

AVWAP (52w high)1.64

vs AVWAP high-33.78%

AVWAP (52w low)1.28

vs AVWAP low-15.21%

OBV trendFlat

Chaikin MF (20)-0.41

Today vs 20d1.53×

Avg vol (14d)1.54M

Avg vol (20d)1.52M

Avg $ vol (20d)1.73M

Market cap89.27M

RS 3m (vs SPY)-42.19%

RS 6m (vs SPY)-59.49%

RS line new highNo

Trend template0/8

Technical rank11.5

1 week-2.25%

1 month-13.89%

3 months-29.55%

6 months-51.78%

1 year-47.33%

YTD-35.80%

P/E-1.05

P/B14.71

P/S—

P/FCF-1.00

EPS-1.81

Div yield—

ROE—

ROA-170.65%

Debt/Eq10.34

Current1.04

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-69.99%

EPS growth20.80%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value125.75M

Revenue0

Net income-19.68M

Gross profit—

Free cash flow-88.92M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out82.27M

Employees112

ListedTue, Dec 8, 1998

Free float68.18M

Float %99.2%

Short interest16.27M

Days to cover5.8d

Short volume56.7%

Squeeze score84 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction11 / 100

Pattern quality—

Tech rank11.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.62

Support1.06

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INO

All disclosures →

No recent disclosed trades by Congress in INO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in INO · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Weiner David B. Director · Common Stock Options · 2026-05-20	Grant	41.8K	$0	2026-05-20	2026-05-21
Miller Ann Calby Director · Common Stock Options · 2026-05-20	Grant	41.8K	$0	2026-05-20	2026-05-21
Humeau Laurent Chief Scientific Officer · Common Stock · 2026-05-20	Tax	2.16K	$3K	2026-05-20	2026-05-21
Shea Jacqueline Elizabeth Chief Executive Officer · Common Stock · 2026-05-20	Tax	12.31K	$15K	2026-05-20	2026-05-21
Shea Jacqueline Elizabeth Chief Executive Officer · Common Stock · 2026-05-20	Exercise	28.3K	—	2026-05-20	2026-05-21
Sumner Michael John Chief Medical Officer · Restricted Stock Unit · 2026-05-20	Exercise	9.45K	$0	2026-05-20	2026-05-21
Sumner Michael John Chief Medical Officer · Common Stock · 2026-05-20	Tax	2.69K	$3K	2026-05-20	2026-05-21
Zoth Lota S. Director · Common Stock Options · 2026-05-20	Grant	41.8K	$0	2026-05-20	2026-05-21
YARNO WENDY L Director · Restricted Stock Unit · 2026-05-20	Grant	34.2K	$0	2026-05-20	2026-05-21
KIES PETER CFO · Common Stock · 2026-05-20	Exercise	8.7K	—	2026-05-20	2026-05-21

SEC filings

EDGAR filings in INO

EDGAR →

No recent SEC filings on file for INO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.